TGFB1 and bacterial infectious disease: Thus, we have identified the protective immune pathway triggered by AAD: transiently heightened levels of TGF-β result in suppression of IFN-γ expression, and this in turn prevents IFN-γ–alveolar macrophage interactions that would otherwise inhibit antibacterial immunity and cause enhanced susceptibility to secondary bacterial infections.